Mission Statement

The mission of the Wyoming State Board of Pharmacy is to promote and protect the health and safety of the public by regulating the practice of pharmacy.

Recent Announcements

WORx Website Update

Users should once again be able to obtain patient reports using either the generate PDF or CSV options. "Forgot Password" should now be working correctly as well. Users who have forgotten their password can use that link to reset their password. Once submitted a new password will be emailed to the users email account on file with the WORx database.

NCDQS QAS Accreditation Recognized by the Board

At the June 16-17, 2021 Board meeting, the Wyoming State Board of Pharmacy recognized the National Coalition for Drug Quality & Security's (NCDQS) Quality and Security Accreditation Program (QAS) as an alternative to the National Association of Boards of Pharmacy's (NABP) Drug Distributor Accreditation (DDA), formerly known as Verified-Accredited Wholesale Distributors (VAWD).

Issuing and Dispensing Prescriptions for Controlled Substances in 2021

As a reminder, pursuant to Wyoming Statute 35-7-1030, controlled substances are now required to be electronically prescribed. The requirements for electronic prescribing systems and exemptions to the electronic prescribing requirement can be found in the Wyoming Controlled Substances Act Rules Chapter 10.

Distribution of controlled substances

It is the Board’s understanding that many resident pharmacies have been distributing controlled substances to practitioners for office dispensing. While the Board does not prohibit this practice, there are many requirements that should be followed in order for pharmacies to be compliant with federal law.

The Board strongly encourages all licensees that may be engaged in this activity to review their current processes to ensure compliance with state and federal law. The following federal provisions are being provided to aid in that review. As a reminder, the Board’s rules and DEA regulations prohibit prescriptions from being issued in order for practitioners to obtain controlled substances for supplying the practitioner for the purpose of general dispensing to patients.

  • 21CFR1304.22 - Records for manufacturers, distributors, dispensers, researchers, importers, exporters, registrants that reverse distribute, and collectors

  • 21CFR1305.03 - Distributions requiring a Form 222 or a digitally signed electronic order

  • 21CFR1305.06 - Persons entitled to fill orders for C-I and C-II substances

  • 21CFR1307.11 - Distribution by dispenser to another practitioner

The Board would like to remind all pharmacies that if they are engaged in this practice, it would be considered distribution. Licensees should not be reporting the distribution of controlled substances as prescriptions into the Wyoming Online Prescription Database (WORx). Please direct any questions to the Board office in writing to bop@wyo.gov.

Butalbital Schedule Status in Wyoming

It has come to the Board's attention that there are questions surrounding butalbital scheduling. The Wyoming Controlled Substances Act (Wyoming Statute 35-7-1018(c)(iii)) lists “any substance which contains any quantity of a derivative of barbituric acid or any salt thereof" as a schedule III-controlled substance. While there are butalbital products listed on the DEA’s list of Exempted Prescription Products, including Fioricet (butalbital/acetaminophen/caffeine), Wyoming does not have a similar list of exempted products. All butalbital-containing products, therefore, are schedule III-controlled substances in Wyoming and must be treated as such.

1712 Carey Ave. Ste 200 Cheyenne, WY 82002

Phone: 307-634-9636 Fax: 307-634-6335

bop@wyo.gov